TILs

TILs

Tumor-infiltrating lymphocytes (TILs) is a type of immunotherapy that uses TILs to treat cancer. In TIL therapy, TILs are collected from a patient’s tumor, grown in the lab, and then reinfused into the patient. The hope is that the TILs will be able to recognize and kill cancer cells.

TIL therapy is not a cure for cancer, but it can help to prolong life and improve the quality of life for some patients. The risks and benefits of TIL therapy should be discussed with a doctor before deciding if it is the right treatment for a patient.

Here are some of the advantages of TIL therapy:

• It is a personalized treatment that uses the patient’s own cells.
• It can be used to treat tumors that are resistant to other treatments.
• It has the potential to be a long-term treatment.

Overall, TIL therapy is a promising new treatment for cancer. It is still in the early stages of development, but it has shown promise in the treatment of some types of cancer. More research is needed to determine the best way to use TIL therapy and to improve its effectiveness.